Adult Giant Cell Glioblastoma [clinicaltrials_resource:d922bb97e47254532dba9d950965e18b]
clinicaltrials:NCT00004146Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme [clinicaltrials:NCT00004262]Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [clinicaltrials:NCT00005856]Bortezomib in Treating Patients With Recurrent Glioma [clinicaltrials:NCT00006773]Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [clinicaltrials:NCT00014170]CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme [clinicaltrials:NCT00016328]Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [clinicaltrials:NCT00030498]Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors [clinicaltrials:NCT00039494]Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma [clinicaltrials:NCT00045110]Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma [clinicaltrials:NCT00045565]A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas [clinicaltrials:NCT00045708]Tipifarnib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma [clinicaltrials:NCT00049387]Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme [clinicaltrials:NCT00052208]Tipifarnib and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [clinicaltrials:NCT00058097]Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme [clinicaltrials:NCT00075491]Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [clinicaltrials:NCT00085254]FR901228 in Treating Patients With Recurrent High-Grade Gliomas [clinicaltrials:NCT00085540]Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma [clinicaltrials:NCT00093613]Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors [clinicaltrials:NCT00110032]clinicaltrials:NCT00112736Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme [clinicaltrials:NCT00112866]clinicaltrials:NCT00238303Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas [clinicaltrials:NCT00268385]AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme [clinicaltrials:NCT00305656]clinicaltrials:NCT00305864Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [clinicaltrials:NCT00316849]clinicaltrials:NCT00329719Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma [clinicaltrials:NCT00335764]VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide [clinicaltrials:NCT00369590]Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma [clinicaltrials:NCT00379080]Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme [clinicaltrials:NCT00390299]clinicaltrials:NCT00423735Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma [clinicaltrials:NCT00430079]Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [clinicaltrials:NCT00445588]Pazopanib in Treating Patients With Recurrent Glioblastoma [clinicaltrials:NCT00459381]Sunitinib in Treating Patients With Recurrent Malignant Gliomas [clinicaltrials:NCT00499473]Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [clinicaltrials:NCT00540722]clinicaltrials:NCT00641706Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma [clinicaltrials:NCT00650923]Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma [clinicaltrials:NCT00662506]
condition [clinicaltrials_vocabulary:condition]
Adult Giant Cell Glioblastoma [clinicaltrials_resource:d922bb97e47254532dba9d950965e18b]
Bio2RDF identifier
d922bb97e47254532dba9d950965e18b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d922bb97e47254532dba9d950965e18b
identifier
clinicaltrials_resource:d922bb97e47254532dba9d950965e18b
title
Adult Giant Cell Glioblastoma
@en
label
Adult Giant Cell Glioblastoma [clinicaltrials_resource:d922bb97e47254532dba9d950965e18b]
@en